The forecast the infusion systems market in Japan to grow at a CAGR of 6.62% during the period 2016-2020.
Infusion Systems Market in Japan 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
A trend which is positively impacting the market is the availability of IT-enabled devices. Advances in technology and incorporation of IT-enabled components have significantly increased the efficiency of infusion systems. IT-enabled infusion systems offer advanced features, such as automatic recording of information regarding fluid flow, and optimal use of nutrients, fluid, and blood with less wastage and leakage.
These features help enhance patient safety, reduce medical errors, increase the efficacy of dosages, and streamline information processing. IT-enabled infusion systems also help reduce costs and timelines associated with treatments.
According to the report, a key growth driver is the rising use of chemotherapy. Over the past few years, chemotherapy is gaining popularity as a treatment option for cancer. The therapy involves the infusion of cytotoxic anti-neoplastic drugs and other medications directly into the bloodstream to inhibit the growth and spreading of cancer cells.
Infusion systems provide short-term access to the bloodstream. Physicians use these systems to deliver chemotherapeutic agents to individuals receiving chemotherapy once every few weeks. Integrated or closed catheters offer fully (360 degrees) encased needle tip protection and have a passive design to minimize needle-stick injuries.
Further, the report states that one challenge that could restrict market growth is the complications associated with infusion systems.
- B. Braun Melsungen
- Fresenius Kabi
Other prominent vendors
- Smiths Medical
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market profile: Japan
Part 06: Healthcare system in Japan
Part 07: Key insights
Part 08: Complications of infusion systems: A global perspective
Part 09: Market landscape
Part 10: Market segmentation by product
Patient-controlled analgesia pumps
Part 11: Market segmentation by application
Part 12: Market drivers
Part 13: Impact of drivers
Part 14: Market challenges
Part 15: Impact of drivers and challenges
Part 16: Market trends
Part 17: Vendor landscape
For more information visit http://www.researchandmarkets.com/research/pjhk2v/infusion_systems
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---japan-infusion-systems-market-2016-2020-with-b-braun-melsungen-baxter-bd-fresenius-kabi-hospira-jms-nipro--terumo-dominating-300300586.html
SOURCE Research and Markets